Further evidence indicates that IL-33 inhibits cell apoptosis by activating p38 mitogen-activated protein kinase (MAPK) pathway in both human AML cell line and AML patient samples, thereby supporting an important role of IL1RL1/IL-33 axis in maintaining AML development [9,10]. Here, IL33 is linked to acute myeloid leukemia.